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Abstract
Background: Sialidosis is a rare lysosomal storage disorder characterized by deficiency of alpha-N-acetyl neuraminidase.
The macular cherry-red spot, which could be important for diagnosis, is a distinctive feature of its ocular manifestation.
We evaluated the fundus autofluorescence (FAF) and optical coherence tomography (OCT) images of a juvenile patient
who presented with vision decrease and was later confirmed with genetic sialidosis.
Case presentation: A 13-year-old Chinese male presented with bilateral decreased vision over the past 2 years before
his initial visit. Funduscopic examination revealed a macular cherry-red bilateral spot. FAF showed hyperreflective areas
surrounding a central hyporeflective fovea in both eyes. OCT revealed increased reflectivity in the ganglion cell layer in
both maculae without a definite boundary between the hyperreflective and normal areas. These findings suggested that
lipofuscin had accumulated in the retinal ganglion cells, which is a distinctive ocular feature in metabolic central nervous
system (CNS) disorders. He was later confirmed with genetic sialidosis.
Conclusions: FAF and OCT images are very sensitive and useful techniques for diagnosing lysosomal storage disease of
the CNS, and are helpful in evaluating the extent of damage in retinal ganglion cells.
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Background
The macular cherry-red spot was first named by Bernard
Sachs. It is a very distinctive ocular manifestation of
central retinal artery occlusion, traumatic retinal edema,
and many neurological metabolic disorders such as
Sandhoff disease, galactosialidosis, GM1 and GM2 gang-
liosidosis, and sialidosis types I and II [1]. Sialidosis is a
rare lysosomal storage disorder characterized by defi-
ciency of alpha-N-acetyl neuraminidase. It is transmitted
as an autosomal recessive trait and is caused by a muta-
tion in the neuraminidase (NEU) gene. There is a wide
clinical spectrum ranging from nearly asymptomatic to
severe presentations. The clinical features of sialidosis
type I include late-onset, cerebellar ataxia, myoclonic
epilepsy, nystagmus, as well as progressive visual loss
[2–4]. The macular cherry-red spot is a very distinctive
ocular feature for differential diagnosis of various CNS
storage diseases [5]. We evaluated the fundus autofluo-
rescence (FAF) and the optical coherence tomography
(OCT) imaging in a juvenile patient presenting with a
vision decrease, who was later confirmed with genetic
sialidosis.
Case presentation
A 13-year-old Chinese male complained of vision de-
creased over the past 2 years, and had an unbalanced gait
as reported by his parents. He was a high school student
with normal intelligence and without smoking or alcohol
abuse. His past medical history and family history were
unremarkable. A neuro-ophthalmological examination
revealed the patient to be alert and oriented. The best-
corrected visual acuities (BCVA) were 20/100 OU. Color
vision (Ishihara plates) was 1/8 OU. Slit lamp examination
showed a punctate cataract and funduscopic examination
revealed macular bilateral cherry-red spots and normal
optic discs (Fig. 1). There was no nystagmus. The deep
tendon reflexes were generally decreased with ataxia and
slight myoclonus of the upper and lower limbs.
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FAF images (Heidelberg Engineering, Heidelberg,
Germany) showed a patch of hyperreflective areas sur-
rounding a hyporeflective fovea in both eyes (Fig. 2).
OCT revealed increased reflectivity in the ganglion cell
layer in both maculae, which corresponded to the
hyperreflective areas on FAF; however, the boundaries
between the hyperreflective and normal regions were
not clear (Fig.3).
Laboratory test results showed normal levels of β-
galactosidase, hexosaminidase A and B, arylsulfatase A,
and β-galactocerebrosidase. Genetic analysis revealed
two compound heterozygous mutations in the NEU1
gene.
Because there was no treatment for sialidosis, the pa-
tient was only followed-up by his ophthalmologist and
neurologist. His visual function was stable after a follow-
up of 1 year.
Conclusions
Sialidosis is a rare autosomal recessive disorder resulting
from a deficiency of alpha-N-acetyl neuraminidase caused
by a mutation in the NEU gene located on 6p21.33. This
results in abnormal intracellular accumulation of sialyloli-
gosaccharides, especially in brain neurons and in ganglion
cells of the retina. A definitive diagnosis involves confirm-
ation of a NEU gene mutation or a deficiency of neuramin-
idase activity in leukocytes and cultured fibroblasts using
skin biopsies [2, 3].
Sialidosis is clinically classified as two major pheno-
types: type I, a cherry-red spot myoclonus syndrome
without dysmorphism, and type II, a more severe infant-
ile form with dysmorphism [4]. Our case presented with
bilateral cherry-red spots and myoclonus without mental
deterioration and dysmorphism, which was consistent
with type I.
The retinal ganglion cells are part of the CNS neurons.
Retinal ganglion cell microstructure can be observed
using an ophthalmoscope or by OCT. In the OCT
images of the patient, abnormal hyperreflective areas
were detected in the ganglion cell layer; however, the
boundaries between the hyperreflective areas and the
normal retinas were not clear [6, 7]. FAF imaging of the
patient revealed bilateral hyperautofluorescent lesions
surrounding a small hyporeflective center, the fovea.
Because lipofuscin, which can be detected by excitation
at 488 nm, is the primary source of retinal autofluores-
cence, the hyperreflective areas in retinal lesions indicate
intracytoplasmic accumulation of lipofuscin-like granules
Fig. 1 Fundus photographs, showing a cherry-red spot in both maculae
Fig. 2 Fundus autofluorescence (FAF) imaging, showing bilateral hyperreflective areas surrounding the fovea
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from a metabolic disease such as sialidosis [8]. There are
two interpretations for the retinal cherry-red spots in siali-
dosis. One is the deposition of lipofuscin granules in the
ganglion cell layer in the perifoveal areas that result in a
white patch around the fovea. Alternatively, the foveal pit
lacks ganglion cells, and thus continues to maintain its
reddish appearance [9].
In conclusion, when evaluating a patient with a
cherry-red spot in the macula, which is not due to arter-
ial occlusion or trauma, the diagnosis should consider
various forms of lysosomal storage diseases. It is import-
ant to note that ophthalmic images using FAF and OCT
are very sensitive and useful methods for detecting
neurological metabolic disorders presenting with a
cherry-red spot in the macula.
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Fig. 3 Optical coherence tomography (OCT) imaging, showing thickening and increased reflectivity in the ganglion cell layer (GCL) in bilateral
eyes. The boundary between the GCL and the nerve fiber layer (NFL) is unclear. IPL = inner plexiform layer
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